Left atrial enlargement: a prevalent marker of hypertensive heart disease.

about

Left atrial enlargement: a prevalent marker of hypertensive heart disease.

Item

http://www.wikidata.org/entity/Q54485627

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Left atrial enlargement: a prevalent marker of hypertensive heart disease.

@en

Left atrial enlargement: a prevalent marker of hypertensive heart disease.

@nl

type

Item

label

Left atrial enlargement: a prevalent marker of hypertensive heart disease.

@en

Left atrial enlargement: a prevalent marker of hypertensive heart disease.

@nl

prefLabel

Left atrial enlargement: a prevalent marker of hypertensive heart disease.

@en

Left atrial enlargement: a prevalent marker of hypertensive heart disease.

@nl

P1476

Left atrial enlargement: a prevalent marker of hypertensive heart disease.

@en

P2093

Eva Gerdts

http://www.w3.org/2001/XMLSchema#string

P2860

The predictive value of left atrial size for incident ischemic stroke and all-cause mortality in African Americans: the Atherosclerosis Risk in Communities (ARIC) Study.

In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.

Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.

Left atrial size in hypertensive men: influence of obesity, race and age. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Left atrial size and the risk of ischemic stroke in an ethnically mixed population.

Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents.

Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.

Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter?

Electrocardiographic changes reflecting left atrial abnormality in hypertension.

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

P304

71-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3109/08037051.2012.677511

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22452334

http://www.w3.org/2001/XMLSchema#string